The glioma data downloaded from the TCGA database indicated that NR5A2 was significantly increased in glioma tissue (Figure 1a), and survival analysis result showed that patients with high NR5A2 expression in glioma suffered poor prognosis (Figure 1b). The gene discussed is NR5A2; the disease is central nervous system cancer.